WilliamHMeyerMD

PubMed

• 9 citations
  The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft T...
  Monika Sparber-Sauer, Andrea Ferrari, Sheri L Spunt, Christian Vokuhl, Dana Casey
  Cancer Medicine. 2023-05-01
• 16 citations
  The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.
  Andrea Ferrari, Daniel Orbach, Monika Sparber-Sauer, David O Walterhouse, Kristian W Pajtler
  European Journal of Cancer. 2022-07-01
• 17 citations
  Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
  Jacquelyn N Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A S Arndt
  Pediatric Blood & Cancer. 2022-06-01

Journal Articles

• Ovarian involvement in neuroblastoma.  
  Meyer WH, Yu GW, Milvenan ES, Jeffs RD, Kaizer H, Leven¬thal BG, Med Pediatr Oncol
• Insulin binding to the HL 60 human promyelocytic cell line.  
  Rogol AD, Meyer WH, Johnson ML, Mol Cell Endocrinol
• Abnormalities of the spleen and liver in patients with hemophilia.  
  Meyer WH, Levin J, Ness PM, Bell WR, Douglass KH, Carmargo EE, Zinkham WH, Am J Hematol
• Changes in actin content during induced myeloid maturation of human promyelocytes.  
  Meyer WH, Howard TH, Blood
• Chemotactic peptide modulation of actin assem¬bly and locomotion in neutrophils.  
  Howard TH, Meyer WH, J Cell Biol
• Pancreatitis following cisplatin: A case report.  
  Bunin N, Meyer WH, Christensen M, Pratt CB, Cancer Treat Rep
• Treatment of unresectable or metastatic oste¬osarcoma with cisplatin or cisplatin doxorubicin.  
  Pratt CB, Champion JE, Senzer N, Green AA, Rao B, Douglass E, Meyer WH, Crom DB, Cancer
• Central nervous system toxicity following treatment of pediatric patients with ifosfamide/mesna.  
  Pratt CB, Green AA, Horowitz ME, Meyer WH, Etcubanas E, Douglass E, Hayes FA, Thompson E, Wilimas J, Igarashi M, J Clin Oncol
• Hypoxanthine: Guanine phosphoribosyltransferase activity in human osteosarcoma xenografts.  
  Meyer WH, Houghton JA, Lutz PJ, Houghton PJ, Cancer Res
• Enhancement of methotrexate nephrotoxicity after cisplatin therapy.  
  Goren MP, Wright RK, Horowitz ME, Meyer WH, Cancer
• Thoracotomy for pulmonary metastatic osteosarcoma: An analysis of prognostic indicators of survival.  
  Meyer WH, Schell MJ, Kumar APM, Rao BN, Green AA, Champion J, Pratt CB., Cancer
• A rationale for therapy with methotrexate thymidine rescue?  
  Meyer WH, Houghton JA, Houghton PJ, J Clin Oncol
• Uri¬nary N acetyl ß D glucosaminidase and serum creatinine concentrations pre¬dict impaired excretion of methotrexate.  
  Goren MP, Wright RK, Horowitz ME, Crom W, Meyer WH, J Clin Oncol
• Phase II trial of ifosfamide in children with malignant solid tumors.  
  Pratt CB, Horowitz ME, Meyer WH, Etcubanas E, Thompson EI, Douglass EC, Wilimas JA, Hayes FA, Green AA, Cancer Treat Rep
• Scheduling of vincris¬tine: Drug accumulation and response of xenografts of childhood rhabdomyo-sarcoma determined by frequency of administration.  
  Houghton JA, Meyer WH, Houghton PJ, Cancer Treat Rep
• Actin polymerization and its relationship to locomotion and chemokinetic response in maturing human promyelocytic leukemia cells.  
  Meyer WH, Howard TH, Blood
• Removal of methotrexate, leucovorin and their metabolites by combined hemodialysis and hemoperfusion.  
  Relling MV, Stapleton FB, Ochs J, Jones DP, Meyer W, Wainer IW, Crom WR, McKay CP, Evans WE, Cancer
• Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity.  
  Look AT, Douglass EC, Meyer WH, N Engl J Med
• Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.  
  Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK, Meyer WH, Gigliotti F, Sixbey JW, Santana VM, Feldman S, Lott L, N Engl J Med
• Mesna-induced urticaria.  
  Pratt CB, Sandlund JT, Meyer WH, Cain AM, Drug Intell Clin Pharm
• Therapy for localized Ewing's sarcoma of bone.  
  Hayes FA, Thompson EI, Meyer WH, Kun L, Parham D, Rao B, Kumar M, Hancock M, Parvey L, Magill L, Hustu HO, J Clin Oncol
• Dextromethorphan and caffeine as probes for simultaneous determina¬tion of debrisoquin-oxidation and n-acetylation phenotypes in children.  
  Evans WE, Relling MV, Petros WP, Meyer WH, Mirro J, Crom WR, Clin Pharmacol Ther
• Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.  
  Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, Meyer WH, J Clin Oncol
• Clinical studies of ifosfamide/mesna at St. Jude Children's Research Hospital.  
  Pratt CB, Douglass EC, Etcubanas E, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA, Semin Oncol
• Phase I study of 4'-deoxydoxorubicin (esorubicin) in children with malignant solid tumors.  
  Pratt CB, Douglass EC, Meyer WH, Hayes FA, Horowitz ME, Thompson EI, Avery L, Invest New Drugs
• Join now to see all

Books/Book Chapters

• Osteosarcoma Studies at St. Jude Children's Research Hospital from 1968 through 1990. 
  Chapter: Controversies and Current Practice 
  Page 323 - 326Pratt CB, Meyer WH, Rao BN, Parham DM, Fleming IDEditors: Humphrey GB.Pediatric Oncology Kluwer Academic Publishers
• Rhabdomyosarcoma and the undifferentiated sarcomas. 
  Chapter: Principles and Practice of Pediatric Oncology 
  Wexler LH, Meyer WH, Helman LJEditors: Pizzo PA and Poplack DG.Lippincott William Wilkins, Philadephia, PAEdition 6,
• Soft Tissue Sarcomas. 
  Chapter: Cancer in Children and Adolescents 
  Meyer WH, Stevens MCG, Cripe TEditors: Carroll WL and Findlay JL.Jones and Bartlett, Sudbury MA
• Soft Tissue Sarcomas of Childhood (142k) for Section 37 Pediatric Oncology 
  Chapter: Holland & Frei Cancer Medicine 7 
  Page 2007 - 2012Meyer WHEditors: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Wiechselbaum RR, TS, Holland JF, and Frei E III.BC Decker Inc, Hamilton, Ontario
• Rhabdomyosarcoma and the undifferentiated sarcomas. 
  Chapter: Principles and Practice of Pediatric Oncology 
  Page 971 - 1001Wexler LH, Meyer WH, Helman LJEditors: Pizzo PA and Poplack DG.Lippincott William Wilkins, Publishers, Philadephia, PAEdition 5,
• Soft tissue sarcomas of childhood. 
  Chapter: Cancer Treatment Reviews 
  Page 269 - 280Meyer WH, Spunt SL
• Soft Tissue Sarcomas (142d) for Section 37 Pediatric Oncology. 
  Chapter: Holland & Frei Cancer Medicine 6 
  Page 2377 - 2383Meyer WHEditors: Kufe DW, Pollock RE, Wiechselbaum RR, Bast TC, Gansler TS, Holland JF, and Frei E III.BC Decker Inc, Hamilton, Ontario
• Osteosarcoma. 
  Chapter: Rudolph's Pediatrics 
  Page 1292 - 1295Pratt CB, Meyer WHEditors: Rudolph AM, Hoffman JIE, Rudolph CD.Appleton &Lange, Stamford Connecticut
• Ewing sarcoma/peripheral neuroepithelioma. 
  Chapter: Rudolph's Pediatrics, 20th edition 
  Page 1290 - 1292Meyer WHEditors: Rudolph AM, Hoffman JIE, Rudolph CD.Appleton & Lange, Stamford, Connecticut
• Neoplasms of Bone. 
  Chapter: Nelson Textbook of Pediatrics 
  Page 1467 - 1470Meyer WilliamEditors: Behrman E, Kliegman R, Arvin M, Nelson W.W.B. Saunders Co, Philadelphia PAEdition 15,
• Osteosarcoma. 
  Chapter: Current therapy in oncology 
  Pratt CB and Meyer WHEditors: Foley JF, Armitage JO, Vose Julie M.W.B. Saunders Co, Orlando, FL
• Identification of new chemotherapeutic agents for treatment of childhood solid tumors with a focus on sarcomas. 
  Chapter: Frontiers of Osteosarcoma Research 
  Page 105 - 115Houghton PJ, Meyer WH, Look AT, Houghton JA
• Late effects of cancer therapy. 
  Chapter: Complications of cancer diagnosis and management. 
  Meyer WH, Leventhal BGEditors: Abeloff M.Baltimore: Johns Hopkins University Press, Chapter XV
• Effects of radiation therapy and chemotherapy on hearing. 
  Chapter: Late effects of treatment for childhood cancer 
  Page 7 - 10McHaney V, Kovnar E, Meyer W, Furman W, Schell M, Kun LWiley-Liss, Inc
• Osteosarcoma. 
  Chapter: Rudolph's Pediatrics 
  Page 1207 - 1210Meyer WH, Thompson EIEditors: Rudolph AM.Appleton & Lange, Norwalk, ConnecticutEdition 19,
• Recent developments in genetic mechanisms, assessment, and treatment of osteosarcoma. 
  Chapter: Rudolph's Pediatrics 
  Page 689 - 693Meyer WH
• Ewing's sarcoma. 
  Chapter: Rudolph's Pediatrics 
  Page 1205 - 1207Meyer WH, Thompson EIEditors: Rudolph AM.Appleton and Lange, Norwalk, ConnecticutEdition 19,
• Principles of total care: Rehabilitation. 
  Chapter: Clinical Pediatric Oncology. Clinical Pediatric Oncology 
  Page 285 - 294Meyer WHEditors: Fernbach DJ, Vietti TJ.Mosby Year Book, St. LouisEdition 4,
• Osteosarcoma: clinical features and evolving surgical and chemotherapeutic strategies. 
  Chapter: Pediatric Clinics of North America 
  Page 317 - 348Meyer WH, Malawer MMEditors: Horowitz ME, Pizzo PA.WB Saunders, Philadelphia
• The use of ifosfamide as initial therapy in osteosarcoma. 
  Chapter: Adjuvant therapy of cancer 
  Page 580 - 585Meyer WH, Pratt CB, Schell MJ, Fletcher BD, Marina N, Parham DM, Rao BN, Sandlund JT, Dahl GEditors: Salmon SE.WB Saunders, Philadelphia
• Use of investigational drugs as initial therapy for childhood solid tumors. 
  Chapter: Hematol Bluttransfus 
  Page 141 - 148Meyer WH, Houghton PJ, Horowitz ME, Etcubanas E, Pratt CB, Hayes FA, Thompson EI, Green AA, Houghton JA, Sandlund JT, Crist WM
• Adjuvant chemotherapy in the treatment of osteosarcoma: Results of the multi-institutional osteosarcoma study. 
  Chapter: Recent concepts in sarcoma treatment 
  Page 283 - 290Link MP, Shuster JJ, Goorin AM, Miser A, Meyer WH, Kingston JE, Belasco J, Baker AR, Ayala AG, Vietti TEditors: Ryan JR, Baker LO.Kluwer Academic
• Hematologic emergencies. 
  Chapter: Pediatric emergency medicine 
  Howard TH, Meyer WHEditors: Ehrlich F, Heldrich FJ, Tepas JJ.Aspen, Rockville, Maryland
• Join now to see all

Abstracts/Posters

• Ifosfamide, carboplatin and etoposide (ICE) combined with human granulocyte-macrophage colony-stimulating factor (GM-CSF) in children with recurrent solid tumors.
  Marina N, Shema S, Rodman J, Bowman L, Furman W, Pappo A, Meyer W, Pratt C, ASCO
• Nasopharyngeal rhabdomyosarcoma (NPRMS): clinical features, outcome and significance of persistent radiographic findings.
  Hongeng S, Kaste S, Pappo A, Aggarwal R, Meyer WH, Pratt CB, ASCO Proceedings
• Ethnic neutropenia is not present at diagnosis in African American (AA) children with Hodgkin's disease, neuroblastoma, osteosarcoma or Wilms tumor.
  Wilimas JA, Luo X, Morris R, Meyer WH, ASCO Proceedings
• Toxicity and pharmacodynamics of oral topotecan (POTOPO) in pediatric patients with relapsed solid tumors.
  Bowman LC, Stewart CF, Zamboni WC, Crom WR, Luo X, Heideman R, Houghton PJ, Meyer WH, Pratt CB, ASCO Proceedings
• Satisfaction after limb sparing (LS) and Amputation (AMP) for malignant bone tumors.
  Hudson MM, Tyc VL, Cremer LK, Rao B, Meyer W, Zacher M, Crom D, Pratt CB, SIOP Vienna Austria
• Curative therapy for osteosarcoma without cisplatin-preliminary experience with SJCRH OS-91.
  Meyer WH, Pratt CB, Rao BN, Luo X, Jenkins JJ, Shearer P, Pappo A, Mahmoud H, Neff J, Harper J, SIOP Vienna, Austria
• Second malignant neoplasms (SMN) after primary osteosarcoma (OS).
  Pratt CB, Meyer WH, Rao B, Luo X, Pappo A, Fleming ID, Cain A, Kaste SC, SIOP Vienna, Austria
• Comparison of primary osteosarcoma (OS) of flat bones with secondary OS of any site.
  Pratt CB, Meyer WH, Rao B, Pappo A, Fleming ID, Luo X, Cain A, Shearer P, Kaste SC, SIOP Vienna, Austria
• Limb salvage for skeletal sarcoma in children and adolescents.
  Rao BN, Lynch M, Meyer W, Pappo A, Bowman L, Kaste SC, Pratt CB, Cremer L, Neel M, SIOP Vienna, Austria
• Therapy related malignant fibrous histiocytoma: St. Jude Children's Research Hospital Experience.
  Mahmoud HH, Parham DM, Rao B, Greenwald C, Douglass E, Pratt C, Meyer W, Med & Ped Oncol
• Ifosfamide window therapy for previously untreated osteosarcoma.
  Meyer WH, Luo X, Parham DM, Rao BN, Pratt CB, AACR Proceedings
• Brain metastases in pediatric patients with ewing sarcoma (ES), and rhabdomyosarcoma (RMS).
  Pappo A, Hazard M, Cain A, Rao B, Meyer W, ASCO Proceedings
• A phase I/II trial of subcutaneous (SC) interleukin-1 (rhuIL-1) administered pre-chemotherapy in pediatric patients with malignant solid tumors.
  Furman W, Fairclough D, Garrison L, Marina N, Avery L, Pratt C, Bowman L, Santana V, Bleyer A, Rodman J, Meyer W, ASCO
• Phase I study of topotecan for pediatric patients with drug resistant solid tumors.
  Pratt C, Stewart C, Santana V, Bowman L, Meyer W, Sandlund J, Furman W, Heideman R, Kuttesch J, ASCO
• Controlling carboplatin pharmacokinetic variability in pediatric cancer patients.
  Rodman J, Murry DJ, Marina N, Madden T, Sandlund T, Furman W, Meyer W, ASCO
• Received dose intensity (RDI) and outcome in disseminated neuroblastoma (NB) over one year of age.
  Fairclough DL, Furman WL, Bowman LC, Santana VM, Meyer WH, Proc Am Soc Clin Oncol
• Chemotherapy for recurrent osteosarcoma (os): Is it worth it?
  Pappo A, Meyer W, Marina N, Mahmoud H, Pratt C, Proc Am Soc Clin Oncol
• Carboplatin (carbo), ifosfamide (ifos) etoposide (VP-16), combination chemotherapy (ICE) for recurrent pediatric solid tumors using escalating targeted doses of carbop...
  Marina N, Rodman J, Shema S, Madden T, Douglass E, Furman W, Bowman L, Meyer W, Pratt C, Proc. Am Soc Clin Oncol
• Impact of irradiation on local control in advanced neuroblastoma.
  Fontanesi J, Bowman L, Hancock M, Furman W, Santana V, Meyer W, Kun L, Proc Am Assoc Cancer Res
• Pediatric malignant fibrous histiocytoma: The St. Jude Children's Research Hospital experience.
  Mahmoud H, Meyer W, Rao B, Parham D, Pratt C, Proc Am Cancer Res
• Pediatric phase I/II trial of targeted dose escalation for carboplatin in combination with ifosfamide/etoposide.
  Marina N, Madden T, Rodman J, Douglass E, Furman W, Bowman L, Hudson M, Meyer W, Pratt C, Proc Am Soc Clin Oncol
• Ifosfamide/etoposide (ifos/VP 16) in patients with previously untreated Ewing's sarcoma or primitive neuroectodermal tumors (PNET).
  Meyer WH, Pratt CB, Thompson EI, Marina N, Kun L, Parham D, Rao B, Fletcher B, Roberson P, Proc Am Soc Clin Oncol
• Ifosfamide (IFOS) and carboplatin (CARBO) window therapy in previously untreated osteosarcoma (OS).
  Meyer WH, Pratt CB, Harper J, Fletcher B, Kaste S, Luo X, Mahmoud H, Parham D, Rao BN, ASCO, Los Angeles, CA
• Bone sarcomas of the head and neck in children: St. Jude Children's Research Hospital Experience.
  Daw NC, Mahmoud HH, Meyer WH, Pratt CB, Rao BN, SIOP, Vienna, Austria
• Adjuvant chemotherapy of osteosarcoma: end results of the multi-institutional osteosarcoma study (MIOS).
  Link MP, Goorin AM, Wexler LH, Meyer WH, Belasco J, Baker A, Ayala A, Shuster JJ, SIOP, Vienna, Austria
• Join now to see all

Lectures

• Rhabdomyosarcoma and Soft Tissue Sarcomas. 
  Insights, Inc CME Course, sponsored by MD Anderson Cancer Center
• Rhabdomyosarcoma: Clinical and Biologic Prognostic Features and Controversies in Therapy. 
  2008 MBTMO/AAOS Research Symposium, Salt Lake City
• Rhabdomyosarcoma: Clinical Features and the COG Therapeutic Trials. 
  ASCO Educational Session, ASCO Annual Meeting
• Update on COG soft tissue sarcoma trial. 
  Spring MMT Meeting, Paris, France
• Update on Childhood Sarcomas. 
  University of New Mexico Annual Pediatric Symposium
• Cancer in Children and Adolescents: Primary Care Update. 
  OU Family Medicine Annual Symposium
• Breaking Windows, new approaches to rhabdomyosarcoma. 
  Memorial Sloan Kettering Cancer Center Pediatric Grand Rounds
• Clinical studies and biology update – soft tissue sarcomas. 
  Invited lecture. Westmead Children’s Hospital, Sydney, New South Wales, Australia
• Current IRS/COG Sarcoma Studies. 
  2004 ANZCHOG Annual Meeting, Coolum, Queensland, Australia
• Soft Tissue Sarcomas in Children and Adolescent. 
  2002 ASCO Education Session, Orlando, FL
• Research Directions in rhabdomyosarcoma. 
  Kyoto University, Kyoto
• The Intergroup Rhabdomyosarcoma Study Results. 
  Japanese Society for Pediatric Oncology, Tokyo
• Prosthetic Management of the Oncology Patient. 
  American Academy of Orthotists and Prosthetists Symposium, Dallas, Texas
• Therapeutic Approaches for Rhabdomyosarcoma. 
  Texas Children’s Cancer Center Research Conference, Houston, Texas
• Topotecan in Rhabdomyosarcoma – for Topoisomerase I Targeted Drugs in Pediatric Cancer Current and Future Directions. 
  International Symposium. Memphis, TN
• Overview of Childhood Cancer. 
  Southwest Medical Center, Oklahoma City, OK
• Neutrophil Disorders. 
  LeBonheur Grand Rounds
• Pediatric Cancer: When should you worry? 
  24th annual Pediatric Dept. CME Meeting
• Treatment of Osteogenic Sarcoma. 
  Pediatric Research Conference, 1997; UT Southwestern Children’s Hospital, Dallas, TX
• Childhood Cancer. 
  Oklahoma Oncology Nursing Society
• Upfront Window Trials in Osteosarcoma. 
  Vanderbilt University Department of Pediatrics
• SJCRH Experience with Osteosarcoma. 
  Children’s Hospital of Oklahoma Pediatric Grand Rounds
• Experience at SJCRH with Bone Tumors. 
  InstitutoNacional de Cancer, Rio de Janeiro, Brazil
• Treatment of Osteosarcoma. 
  St. Jude Children's Research Hospital
• Treatment of Ewing Sarcoma - II Simposio International de Tumores Osseso. 
  Sarcomas dos Tecidos Moles Sao Paulo, Brazil
• Join now to see all